Accueil › Cancer de la vessie › Missouri › St. Louis
Essais cliniques pour Cancer de la vessie à St. Louis, MO
22 études pour Cancer de la vessie recherchent des participants dans et autour de St. Louis (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Recrutement en coursPhase 1
- Washington University School of Medicine in St. Louis, St Louis
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- et 4 autres
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Recrutement en coursPhase 2
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- et 1 autres
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 2
- Washington University, School of Medicine, St Louis
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Recrutement en coursPhase 2
- Cancer Care Center of O'Fallon, O'Fallon · à 16 mi
- HSHS Saint Elizabeth's Hospital, O'Fallon · à 16 mi
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Recrutement en coursPhase 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- et 5 autres
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Recrutement en coursPhase 1/2
- Siteman Cancer Center, St Louis
- Barnes-Jewish Hospital, St Louis
- Washington University School of Medicine - Siteman Cancer Center, St Louis
- et 5 autres
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recrutement en coursPhase 3
- Washington University School of Medicine, St Louis
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
Recrutement en coursPhase 1
- Washington University School of Medicine, St Louis
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Recrutement en coursPhase 1/2
- Washington University, St Louis
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Recrutement en coursPhase 2
- Specialty Clinical Research of St. Louis, St Louis
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Recrutement en coursÉtude observationnelle
- Washington University School of Medicine, St Louis
The Vanguard Study: Testing a New Way to Screen for Cancer
Recrutement en coursVolontaires sains bienvenus
- Washington University School of Medicine, St Louis
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Recrutement en coursPhase 2
- Renown Regional Medical Center, St Louis
- Specialty Clinic Research of St. Louis, St Louis
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Recrutement en coursPhase 3
- Renown Regional Medical Center, St Louis
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Recrutement en coursPhase 1
- Washington University in St. Louis, St Louis
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Recrutement en coursPhase 3
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- et 4 autres
IDOV-Immune for Advanced Solid Tumors
Recrutement en coursPhase 1
- Washington University School of Medicine, St Louis
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Recrutement en coursÉtude observationnelle
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Recrutement en coursÉtude observationnelle
- Washington University, St Louis
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- Washington University, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, St Louis
Essais pour Cancer de la vessie dans d'autres villes
- New York City, NY35 études
- Nashville, TN31 études
- Houston, TX31 études
- Dallas, TX27 études
- Boston, MA26 études
- Washington, DC26 études
- Los Angeles, CA24 études
- Baltimore, MD24 études
- Philadelphia, PA21 études
- Seattle, WA21 études
- Edison, NJ21 études
- Chicago, IL21 études
Autres études à St. Louis
- Cancer du poumon non à petites cellules73 études
- Cancer du sein64 études
- Cancer métastatique54 études
- Cancer colorectal50 études
- Cancer de la prostate46 études
- Cancer (tous types)46 études
- Cancer du poumon39 études
- Cancer de l'ovaire38 études
- Cancer du pancréas33 études
- Cancer de l'endomètre29 études
- Carcinome épidermoïde de la tête et du cou28 études
- Insuffisance cardiaque26 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.